Boston is the apex of today’s biotechnology world. With over 250 companies in Boston, Cambridge, and surrounding suburbs, nearly every pharmaceutical company has a stake in Boston’s biotech network.
Alexander R. Ivanov’s paper, “Mass-Spectrometry-Based Molecular Characterization of Extracellular Vesicles: Lipidomics and Proteomics” was recognized by C&EN’s publication ‘Supplement” as one of the top ten chromatography and mass spectrometry papers.
A short course by Olga Vitek focused on how to keep up in the field of proteomics when the rapid advancements make it tough to interpret and translate meaningful results.
While on co-op at Woods Hole Oceanographic Institution in Cape Cod, Elliott Mueller is testing Martian meteorites and lunar samples from the Apollo missions.
Spencer Martin is working at Ernst & Young as part of the pharmaceuticals team, preparing for and performing mergers and acquisitions of Indian and multi-national pharmaceutical companies.
Kenneth W. Henderson, a scholar of synthetic and structural inorganic chemistry, is a professor and chair of the Department of Chemistry and Biochemistry at the University of Notre Dame. He will join Northeastern on July 1.
Amanda Dell’Olio is responsible for analyzing and maintaining the water quality throughout the Walt Disney World properties.
Dr. Barry Karger has taught at Northeastern University for 53 years, and has spent 43 years as director of the Barnett Institute. But if you ask him about his retirement, he’ll tell you, “I’m not going to just go fishing.”
Isaac Kresse is working for SINTEF in Trondheim, Norway.
The Wolfgang Goetzinger-Amgen Memorial Scholar Award is in memory of Amgen’s well-respected and esteemed colleague, Wolfgang Goetzinger, an analytical chemist at Amgen’s Cambridge R&D facility and former post-doctoral fellow in the Barnett Institute at Northeastern University.